Neos Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Neos Investment Management LLC
- $8.08 Trillion
- Q2 2025
A detailed history of Neos Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 32,050 shares of REGN stock, worth $18.1 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
32,050
Previous 20,886
53.45%
Holding current value
$18.1 Million
Previous $13.2 Billion
27.02%
% of portfolio
0.21%
Previous 0.25%
Shares
8 transactions
Others Institutions Holding REGN
# of Institutions
1,417Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.31 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.72 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.16 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...